Loading...
  • MITIS
  • Chi F, Nolte O, Bergmann C et al (2007) Crossing the barrier: evolution and spread of a major class of mosaic pbp2x in S. pneumoniae , S. mitis and S. oralis . (springer.com)
  • antibiotic
  • S. pneumoniae has developed antibiotic resistance to traditional β-Lactam antibiotics such as Penicillin (and its derivatives). (kenyon.edu)
  • Due to the increasing rate of antibiotic resistance it is important to study newer ways to inhibit S. pneumoniae growth. (kenyon.edu)
  • bacteremia
  • We present a recent case of S. pneumoniae bacteremia acquired on the first day of life in a neonate born at 30 weeks of gestation to a mother without prenatal care who had prolonged rupture of the membranes and received intravenous ampicillin prior to delivery. (pubmedcentralcanada.ca)
  • antigen
  • Routine laboratory testing that was performed at the time of admission included a normal white blood cell count as well as a negative rapid plasma reagin test, hepatitis B surface antigen test, human immunodeficiency virus serology, cervical swabbing for Neisseria gonorrhoeae and Chlamydia trachomatis for a nucleic acid amplification test, urine toxicology screening, and vaginal culture testing for group B streptococcus. (pubmedcentralcanada.ca)
  • antibiotics
  • Competence in S. pneumoniae is induced by DNA-damaging agents such as mitomycin C , fluoroquinolone antibiotics ( norfloxacin , levofloxacin and moxifloxacin ), and topoisomerase inhibitors . (wikipedia.org)
  • A person can no longer spread S. pneumoniae after taking the proper antibiotics for 1-2 days. (virginia.gov)
  • S. pneumoniae has developed increased resistance to multiple classes of antibiotics. (bioportfolio.com)